好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Improving the Safety of Neurocritical Care Transitions through Failure Mode and Effects Analysis (FMEA)
Neuro Trauma, Critical Care, and Sports Neurology
S48 - Neurocritical Care: Traumatic Brain Injury and Goals-of-care Decision-making (2:36 PM-2:48 PM)
009

Failure Mode and Effects Analysis (FMEA) is an engineering methodology that can be applied to neurocritical care to reduce errors in communication during inter-hospital transfer for acute neurological emergencies. We describe the application of FMEA in our institution as evidence for this methodology to proactively reduce errors in acute neurological patient care.

The origin of the approach dates to the 1940s when the US military investigated failures of their systems; subsequently, FMEA spread to aerospace, automotive and healthcare industries for qualitative reliability analyses; in fact, the Joint Commission now requires hospitals to perform FMEA regularly as a model for QI. However, the application of FMEA as an approach to reduce the safety risks in acute neurological care has not been described.

Here we apply FMEA to identify factors of potential hazards in communication for inter-hospital transfers of intracranial hemorrhages.
1) Assemble a multidisciplinary team
2) Define all functions/potential failure modes for each
3) Identify/assess failure mode severity, occurrence, detectability
4) Prioritize high-risk failures, develop interventions
5) Monitor for sustainability, reevaluate

This intervention resulted in reductions in ED throughput (length of stay: 300 to 149 minutes, (p<.01), significant improvements in inter-disciplinary communication, as seen by an increase from pre-intervention (10%) to post- (64%) where NICU and ED attendings discussed the patient prior to arrival, improved guideline adherence, also with anticoagulant reversal agents administered faster, (217 to 165 minutes), though this was not significant (p = 0.53).

Reducing errors in healthcare delivery often requires a redesign of care processes. QI has traditionally been a reactive process; FMEA exemplifies a proactive investigation of hazards prior to patient harm. When embraced this approach may generate solutions easily translated into institutional guidelines and policies. Utilization of FMEA as an instrument of change is a powerful tool for improving timely communication, resource utilization, and patient outcomes.

Authors/Disclosures
Priyanka Chilakamarri, MD (Division of Sleep, Hosp University of Pennsylvania)
PRESENTER
Dr. Chilakamarri has nothing to disclose.
No disclosure on file
No disclosure on file
Kevin N. Sheth, MD, FAAN (Yale UniversityDivision of Neuro and Critical Care) Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Charles Matouk Charles Matouk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Silk Road Medical. Charles Matouk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Charles Matouk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navigantis.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file